Matching slides 110,471
Current window 75,541-75,570
Pages 3,683
Rows per page 30
Component: Listclear collectionreset all

Component

75,541-75,570 of 110,471

filter-aware
10
The slide uses a waterfall chart to show license accumulation and a stacked area chart to show revenue contribution by license vintage.arm | Investor Presentation Deck | 18 slides · Arm
Conference presentation Investor relations 1 hit
13
The slide uses a layered stack diagram to represent the various IP blocks (Software, Security, System, AI/ML, Vision, Graphics, Processor, Physical) that constitute Arm's product offering.arm | Investor Presentation Deck | 18 slides · Arm
Conference presentation Investor relations 1 hit
16
The slide illustrates the 'J-curve' or long-term investment nature of semiconductor R&D.arm | Investor Presentation Deck | 18 slides · Arm
Conference presentation Investor relations 1 hit
17
The chart uses a dual-axis approach to correlate financial metrics with headcount growth.arm | Investor Presentation Deck | 18 slides · Arm
Conference presentation Investor relations Beat · Financials1 hit
18
arm | Investor Presentation Deck | 18 slidesarm | Investor Presentation Deck | 18 slides · Arm
Conference presentation Investor relations 1 hit
03
The slide uses a numbered list to present five key pillars of the company's value proposition.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations Loop · Golden Circle1 hit
08
The slide uses a timeline framework to contrast past performance with future expectations.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
10
The slide uses a split-layout: left side defines the condition and market size, right side outlines the clinical and regulatory pain points.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
11
The slide uses a line chart to demonstrate clinical efficacy over 12 weeks.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
13
The slide uses chemical structures and bar charts to contrast the two enantiomers.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations Beat · Competition1 hit
14
CADSS = Clinician Administered Dissociative States Scale. Data points are plotted over time (Baseline, 15m, 40m, 90m).ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
25
The slide uses a combination of a list-based framework for the 'Massive Unaddressed Need' and a data-heavy section for 'Anxiety in numbers'.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
29
The slide uses a combination of a map, metric callouts, and a vertical timeline-style list to quantify the market opportunity.ATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
39
ATAI | Investor Presentation Deck | 49 slidesATAI | Investor Presentation Deck | 49 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
07
Includes a flywheel diagram representing core values.Azek | IPO Presentation Deck | 43 slides · The AZEK Company
Pitch deck Investment bank Beat · Situation & ContextLoop · Golden Circle1 hit
09
The slide uses a visual grid to categorize products under Residential (Decking, Exteriors, Rail, Accessories) and Commercial (Scranton Products, Vycom).Azek | IPO Presentation Deck | 43 slides · The AZEK Company
Pitch deck Investment bank Beat · Situation & ContextLoop · Golden Circle1 hit
10
Includes two donut charts for portfolio breakdown and two bar charts for financial performance.Azek | IPO Presentation Deck | 43 slides · The AZEK Company
Pitch deck Investment bank Beat · Problem & Complication1 hit
19
Uses a central circular diagram to illustrate the 'early innings' thesis, supported by market size and CAGR data for each segment.Azek | IPO Presentation Deck | 43 slides · The AZEK Company
Pitch deck Investment bank Beat · VisualizationLoop · Cost Of Inaction1 hit
20
The slide uses a combination of visual 'before/after' imagery and stacked bar charts to demonstrate value.Azek | IPO Presentation Deck | 43 slides · The AZEK Company
Pitch deck Investment bank Beat · VisualizationLoop · Cost Of Inaction1 hit
24
Uses a comparison frame to highlight superior warranty and material technology of TimberTech over Trex.Azek | IPO Presentation Deck | 43 slides · The AZEK Company
Pitch deck Investment bank Beat · DesireLoop · Mece Breakdown1 hit
26
Uses a pyramid diagram to illustrate the market structure and a list to detail specific barriers.Azek | IPO Presentation Deck | 43 slides · The AZEK Company
Pitch deck Investment bank Beat · DesireLoop · Mece Breakdown1 hit
33
Includes a visual representation of the recycling process and a timeline of strategic milestones.Azek | IPO Presentation Deck | 43 slides · The AZEK Company
Pitch deck Investment bank Beat · ActionLoop · Hypothesis Test1 hit
35
Azek | IPO Presentation Deck | 43 slidesAzek | IPO Presentation Deck | 43 slides · The AZEK Company
Pitch deck Investment bank Beat · ActionLoop · Hypothesis Test1 hit
41
Azek | IPO Presentation Deck | 43 slidesAzek | IPO Presentation Deck | 43 slides · The AZEK Company
Pitch deck Investment bank Beat · ActionLoop · Hypothesis Test1 hit
07
The slide uses a numbered list format to present key value propositions.Calliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank 1 hit
08
Calliditas Therapeutics | IPO Presentation Deck | 38 slidesCalliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank Beat · Problem1 hit
12
Includes two bar charts showing primary and secondary endpoint results.Calliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank Beat · Product1 hit
13
The slide presents clinical trial safety data comparing Placebo, Nefecon 16mg, and Nefecon 8mg.Calliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank Beat · Product1 hit
16
The slide uses a process flow diagram to illustrate the clinical trial structure (Screening, Part A, Part B).Calliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank 1 hit
18
The slide uses a bulleted list to detail operational resilience in a clinical trial setting.Calliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank 1 hit